Comparison of endometrial thickness in frozen embryo transfer in infertile women

Comparison of endometrial thickness in the frozen embryo transfer (ET) with and without the use of gonadotropin-releasing hormone (GNRH) along with taking estradiol

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130812014333N109

Enrollment

Registered

2018-12-15

Start date

2018-12-06

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Noninflammatory disorders of female genital tract

Interventions

Intervention 1: The intervention group will receive 0.1 mg Gonadotropin-releasing hormone antagonists(GNRH-a) manufactured by Iran Hormones and OC tablets (with the 21 tablets per packs, manufactured

Eligibility

Sex/Gender

Female

Age

No minimum to 42 Years

Inclusion criteria

Inclusion criteria: Less than or equal to 42 years old Less than 10 mL / mIU of FSH level

Exclusion criteria

Exclusion criteria: Patients with asthma, Systemic diseases, Gastrointestinal disorders

Design outcomes

Primary

Measure	Time frame
Endometrial thickness. Timepoint: The beginning and end of the study. Method of measurement: Using an ultrasound machine.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Fassihi

Kermanshah University of Medical Sciences

Drfassihi92@gmail.com+98 83 3427 6306

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026